Onivyde 43 MG/10 ML vial 10ML
Ended Awarded
- Contract number
- SPE2DB25FJJ51
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,383
Award facts
- Contract value 100% obligated
- $21,382.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $21,382.68 for ONIVYDE 43 mg/10 ml vials on August 12, 2025, with completion targeted for September 3, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. ONIVYDE (irinotecan liposome injection) is a specialized oncology medication used in cancer treatment protocols, reflecting the Defense Logistics Agency Medical Supply Chain's procurement of critical pharmaceutical products to support military healthcare operations.
This delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999,999,999 global pharmaceutical prime vendor agreement running through December 2026. The parent IDC enables AmerisourceBergen to supply a comprehensive range of brand-name and generic medications, vaccines, and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. As a major pharmaceutical distributor headquartered in Pennsylvania, AmerisourceBergen serves as a critical vendor for federal medical procurement and has demonstrated capability to fulfill federal requirements through competitive award processes across multiple therapeutic domains and transaction values.
Quick answers
Who was awarded contract SPE2DB25FJJ51?
SPE2DB25FJJ51 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 12, 2025.
How much is contract SPE2DB25FJJ51 worth?
The government has obligated $21,383 on SPE2DB25FJJ51.
Is contract SPE2DB25FJJ51 an order under another contract?
Yes. SPE2DB25FJJ51 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FJJ51 competed?
The extent of competition for SPE2DB25FJJ51 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award